KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elevance Health (ELV) Other Non-Current Assets (2016 - 2025)

Historic Other Non-Current Assets for Elevance Health (ELV) over the last 17 years, with Q4 2025 value amounting to $2.3 billion.

  • Elevance Health's Other Non-Current Assets rose 794.39% to $2.3 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $2.3 billion, marking a year-over-year increase of 794.39%. This contributed to the annual value of $2.3 billion for FY2025, which is 794.39% up from last year.
  • Latest data reveals that Elevance Health reported Other Non-Current Assets of $2.3 billion as of Q4 2025, which was up 794.39% from $2.8 billion recorded in Q3 2025.
  • Over the past 5 years, Elevance Health's Other Non-Current Assets peaked at $2.8 billion during Q3 2025, and registered a low of $1.6 billion during Q1 2021.
  • For the 5-year period, Elevance Health's Other Non-Current Assets averaged around $2.1 billion, with its median value being $2.1 billion (2023).
  • Per our database at Business Quant, Elevance Health's Other Non-Current Assets tumbled by 1473.0% in 2021 and then skyrocketed by 2089.39% in 2024.
  • Over the past 5 years, Elevance Health's Other Non-Current Assets (Quarter) stood at $1.7 billion in 2021, then decreased by 1.63% to $1.7 billion in 2022, then grew by 16.6% to $2.0 billion in 2023, then increased by 8.8% to $2.1 billion in 2024, then rose by 7.94% to $2.3 billion in 2025.
  • Its last three reported values are $2.3 billion in Q4 2025, $2.8 billion for Q3 2025, and $2.6 billion during Q2 2025.